NDNR

Neither selenium nor vitamin E reduces the risk of prostate cancer Jacob Schor, ND In a recent publication of their analysis of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) data, Klein et al1 suggested that daily doses of selenium or vitamin E reduce the risk of prostate cancer. Taking vitamin E may actually [...]

Diverse applications for low-level laser therapy in oncology practice Katherine Neubauer, ND   Heliotherapy, the therapeutic use of sunlight, has long been a core treatment in naturopathic medicine. Current understanding of vitamin Ds importance in oncology supports its value. With the advent of laser technology, the benefit of specific wavelengths of light has been investigated [...]

  Treatment Options Aminah A. Keats, ND, FABNO Ever since oophorectomy was first shown to cause regression of advanced breast cancer more than a century ago, deprivation of estrogenic signaling has been the mainstay of endocrine management of estrogen receptor-positive and progesterone receptor-positive disease.1 Ovarian ablation can be achieved by way of surgical oophorectomy, radiation [...]

When it’s Not Prostate Cancer Clinical rule out strategies for an elevated tPSA Phranq D. Tamburri, NMD Your 60-year-old male patient presents to you with an ‘elevated’ total prostate specific antigen (tPSA) of 3.5 ng/ml. Although his digital rectal exam (DRE) was negative, his primary care practitioner sent him to a urologist who ordered a [...]

Cancer and Anxiety Lena Suhaila, ND Cancer is characterized by a loss of cellular control on the physical level; it follows that it is natural to experience a loss of control on the psychological level resulting in anxiety. Receiving a cancer diagnosis and needing to undergo cancer treatment prompts a high degree of emotional distress [...]

Viral-Associated Cancers Michelle Qaqundah, ND, FABNO It has been just over a century since Ellerman and Bang first demonstrated that transmissible viruses can cause cancer when they linked what later proved to be an avian retrovirus to leukemia.1 Since that time the idea that cancer is of viral origin has come in and out of [...]

Possible Benefit to Cancer Patients Jacob Schor, ND, FABNO Much of what we do in naturopathic oncology is exploration. We find and follow ideas, both old and new, and ask whether they lead to something useful for our patients. This article is about a new angle to consider when working with cancer patients. It is [...]

Overdiagnosis and radical treatment Michael Uzick, NMD Prostate cancer is now the second leading cause of cancer death among men in the United States. The American Cancer Society estimates over 190,000 new cases and over 27,000 deaths from prostate cancer in 2009.1 Yet, men with local disease have a 5-year survival rate of 100%. This [...]

A Case Study Laura A. James, ND   Even before I opened my satellite practice in naturopathic oncology in Bellingham, WA, I got a call from a 37-year-old female, Mrs. R, who was diagnosed in November 2006 with breast cancer. She had been about to start chemotherapy for Stage III, ER/PR+, Her 2 neu – [...]

An Overview of Thyroid Cancer Aminah Keats, ND Cancers of the endocrine system are very uncommon and constitute less than 1% of all malignancies (Casciato, 2004). Thyroid cancer is the most common type of endocrine malignancy, accounting for the majority of deaths due to endocrine cancers (DeVita, 2005). There are 14,000 cases diagnosed each year [...]